Salient Pharmaceuticals' Grant

Salient Pharmaceuticals raised a round of funding on January 06, 2010. Investors include Texas Emerging Technology Fund.

Salient Pharmaceuticals is a life science company developing a proprietary compound intended for use in treating severe diarrhea associated with chemotherapy, chronic conditions, infectious diseases a…

Articles about Salient Pharmaceuticals' Grant: